SRC
BMY icon

Samson Rock Capital’s Bristol-Myers Squibb BMY Stock Holding History

Samson Rock Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,398
Closed -$455K – 25
2022
Q3 		$455K Buy
+6,398
New +$464K 0.34% 22

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Samson Rock Capital's BMY Position: Q4 2022 in Review

Samson Rock Capital sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 6,398 shares — an estimated $455K sold.

Samson Rock Capital first reported a position in BMY in Q3 2022 and held it in 1 quarter. The position peaked at $455K in Q3 2022. 2,601 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

  • Samson Rock Capital reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
  • Samson Rock Capital sold 6,398 Bristol-Myers Squibb shares in Q4 2022, an estimated $455K.
  • Samson Rock Capital first reported a position in Bristol-Myers Squibb in Q3 2022 and held it in 1 quarter.
  • Samson Rock Capital's Bristol-Myers Squibb position peaked at $455K in Q3 2022.
  • 2,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Samson Rock Capital's 13F filing for Q4 2022, filed 7 Feb 2023.